Cover Image
市場調查報告書

臉部美容院市場:已發展市場的認識擴大刺激需求,美國的經濟復甦促進成長

Facial Aesthetics Market to 2020 - Economic Recovery Drives Growth in the US as Increasing Awareness Fuels Demand in Developing Markets

出版商 GBI Research 商品編碼 305020
出版日期 內容資訊 英文 84 Pages
訂單完成後即時交付
價格
Back to Top
臉部美容院市場:已發展市場的認識擴大刺激需求,美國的經濟復甦促進成長 Facial Aesthetics Market to 2020 - Economic Recovery Drives Growth in the US as Increasing Awareness Fuels Demand in Developing Markets
出版日期: 2014年05月30日 內容資訊: 英文 84 Pages
簡介

2013年的全球臉部美容院市值達25億美金,今後將以11%的CAGR成長,預計至2020年達到54億美元。未來的成長,預計由美國等先進各國的經濟持續復甦所促進,在一般市民之間,由對可利用的臉部注射劑的認識擴大所支撐。

本報告提供全球主要國家市場(美國、巴西、德國、土耳其、法國、義大利、西班牙、日本、中國、印度、哥倫比亞及韓國)的臉部美容院市場相關調查、各市場區隔(肉毒桿菌、皮膚填充劑)的市場規模、市場收益資料的預測、市場佔有率資料以及主要趨勢的定性分析,及競爭情形、主要企業的主要技術相關資訊等彙整資料,為您概述為以下內容。

第1章 目錄

第2章 簡介

第3章 分析師的評論

第4章 全球臉部美容院市場:設備概要

  • 臉部美容院

第5章 全球臉部美容院市場:市場特徵附有

  • 全球臉部美容院市場:收益
  • 全球肉毒桿菌市場:主要企業的市場佔有率
  • 全球皮膚填充劑(Dermal Fillers)市場:主要企業的市場佔有率
  • 臉部美容院市場:主要趨勢
  • 市場動態

第6章 全球臉部美容院市場:市場區隔分析與預測

  • 全球肉毒桿菌市場收益
  • 全球皮膚填充劑市場收益

第7章 全球臉部美容院市場:各國分析與預測

  • 臉部美容院市場:各國分析
  • 收益、產量實際成果與預測:各國
    • 美國
    • 日本
    • 德國
    • 法國
    • 韓國
    • 西班牙
    • 義大利
    • 哥倫比亞
    • 中國
    • 土耳其
    • 印度
    • 巴西

第8章 全球臉部美容院市場:競爭情形

  • 主要肉毒桿菌品牌比較
  • 主要玻尿酸為基礎的填充劑比較
  • 全球臉部美容院市場:競爭評估
  • 企業簡介

第9章 全球臉部美容院市場:產品平台分析

  • 臉部美容院市場:開發中產品的清單
  • 臉部美容院市場:主要開發中產品簡介

第10章 臉部美容院市場:整合形勢

  • 主要契約:2014年
  • 主要契約:2009-2013年

第11章 附錄

圖表清單

目錄
Product Code: GBIME0098MR

GBI Research's report, "Facial Aesthetics Market to 2020 - Economic Recovery Drives Growth in the US as Increasing Awareness Fuels Demand in Developing Markets" discusses the market, competitive landscape, and trends for two facial aesthetics market segments: Botox and dermal fillers. It provides comprehensive information on the key trends affecting these segments, and key analytical content on the dynamics of the market. The report also reviews the competitive landscape, analyzes each segment's pipeline products and gives details of important merger and acquisition deals. It is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research's team of industry experts.

Scope

  • Key geographies: US, Brazil, Germany, Turkey, France, Italy, Spain, Japan, China, India, Columbia and South Korea.
  • Information on market size for two facial aesthetics market segments: botox and dermal fillers.
  • Annualized market revenue data forecast to 2020 and company share data for 2013.
  • Qualitative analysis of key trends in the facial aesthetics market.
  • Information on the competitive landscape and the leading technologies of key players: Allergan, Galderma, Merz Pharma, Ipsen, Anteis, Valeant Pharmaceuticals International, Medytox, LIBP, Laboratoires Teoxane and Hugel.

Reasons to buy

  • Develop business strategies by understanding the trends and developments driving the global facial aesthetics market.
  • Design and enhance your product development, marketing, and sales strategies.
  • Exploit merger and acquisition opportunities by identifying the market players with the most innovative pipelines.
  • Develop market-entry and market-expansion strategies.
  • Identify the key players best positioned to take advantage of the emerging market opportunities.
  • Exploit in-licensing and out-licensing opportunities by identifying the products most likely to ensure a robust return.
  • Identify, understand and capitalize emerging blockbusters of the facial aesthetics market landscape.
  • Make more informed business decisions from insightful and in-depth analysis of the global facial aesthetics market and the factors shaping it.

Abstract

Facial Aesthetics Market Expected to Grow Rapidly during the Forecast Period

The following figure shows the projected revenue growth of the global facial aesthetics market during the 2013-2020 period.

The global facial aesthetics market was valued at $2.5 billion in 2013 and is forecast to reach $5.4 billion by 2020, at a CAGR of 11%. Future growth will be driven by sustained economic recovery in developed countries such as the US, aided by increasing awareness among the general public of the facial injectables available to them. The focus of companies such as Allergan on Direct-to-Consumer (DTC) marketing has been effective in expanding patient demographics from exclusively wealthy individuals to a wider range of people. Individuals born during the 1980-1994 period present a significant opportunity for companies in this market to sustain revenue growth in the future as this demographic is seeking age reversal techniques earlier than their predecessors. Recurring revenue from facial injectables encourages beauty clinics and medical practitioners to continue to recommend facial injectables such as Botox and dermal fillers to their patients. Topical neurotoxins which are expected to be launched by early 2016 will have a significant impact on the facial aesthetics market. As patients increasingly prefer non-invasive age reversal techniques, topical neurotoxins will replace injectable Botox products such as Botox Cosmetic and Dysport. Increasing job opportunities for women in developing economies such as India and China is leading to higher disposable income which drives the demand for facial aesthetic procedures. The global facial aesthetics market is highly exposed to economic volatility as aesthetic procedures are elective and purely cosmetic. These procedures lack reimbursement which is another major drawback as any economic uncertainty or insecurity at work may result in people refraining from opting for facial aesthetic procedures.

Allergan Dominates the Global Facial Aesthetics Market

Allergan dominates the global facial aesthetics market with a share of 58% in 2013. The company enjoys dominance in the Botox segment as its brand Botox Cosmetic remains the most preferred brand worldwide, accounting for a 76% share in the global Botox market. The company's presence in the global dermal fillers market stood at 38% at the end of the fiscal year ended 2013. Allergan has been able to sustain its leadership position in both the Botox and dermal filler segments despite the entry of new products such as Dysport in 2009 and Xeomin in 2011. The company has invested heavily in DTC advertising in recent years which has resulted in increasing awareness of the company's facial aesthetic products and their effects. The company's DTC expense stood at $180m in 2013.

Allergan's strong lead in the Botox segment is expected to come under pressure once topical neurotoxins such as RT-001 are approved in the US and rest of the world. Though this will not occur before 2016, the expected impact of topical neurotoxins cannot be understated.

Allergan faces increasing competition in the dermal fillers segment with Valeant Pharmaceuticals holding 22% share in 2013. The competition is more intense in Europe where there are a number of local dermal filler brands that compete with Allergan's Juvederm and Valeant's Restylane line of products. In Asia-Pacific, Medytox is the leader of the Botox segment and competes with Allergan.

In April 2014, Valeant offered to acquire Allergan in a cash and stock purchase consideration of $45.7 billion. However Allergan rejected the deal as the company focuses on its strategy to remain independent and make acquisitions to sustain leadership position in the global facial aesthetics market. If the deal was approved, Valeant would have become the undisputed leader in the global Botox and dermal fillers markets. The deal is in line with Valeant's growth strategy to become one of the largest drug makers in the world and will enable Valeant to be the dominant presence in both the Botox and dermal fillers segments. The deal would have strengthened Valeant's market share in Botox market to 90% and in dermal fillers market to 60%. Valeant would also have benefitted from the robust pipeline portfolio of Allergan and the strong brand loyalty that Allergan has enjoyed over the years for its flagship brands Botox Cosmetic and Juvederm. Allergan's decision to reject the deal followed the company's unsuccessful efforts to convince medical device giants such as Johnson & Johnson and Sanofi to acquire the company.

US will Continue to be the Largest Market for Facial Aesthetics

The US market for facial aesthetics was valued at $1 billion in 2013 and is forecast to reach $2.5 billion by 2020 at a CAGR of 10%. According to the American Society of Aesthetic Plastic Surgery, the frequency of facial aesthetic procedures grew by 21% in 2013 (ASAPS, 2013). The growth of the US facial aesthetics market has been increasing steadily in line with the sustained recovery of the US economy since 2010. The US market grew at 22% in 2012 followed by 21% in 2013. The number of Botox procedures grew by 15.6% in 2013 and the number of Hyaluronic Acid (HA) filler procedures grew by 31%.

Botox Cosmetic, Dysport and Xeomin are the only Botox products approved by the US Food and Drug Administration (FDA). Xeomin was able to join the US market after the completion of its injunction in 2013 due to a lawsuit filed by Allergan. The injunction was against Merz Aesthetics; the manufacturer of Xeomin. It has been proven that Merz recruited Allergan's employees and accessed confidential information related to Botox Cosmetic. This injunction led to Xeomin being banned from the US market for 12 months, whilst legal proceedings took place. The US dermal fillers market is dominated by Allergan and Valeant Pharmaceuticals. Allergan's Botox Cosmetic and Valeant's Restylane accounted for more than 75% of the US dermal fillers market in 2013.

The US market accounted for 42% of the global facial aesthetics market in 2013, which is expected to decrease to 38% by 2020. As awareness of the benefits of facial aesthetic procedures increase in developing countries, the contribution of the rest of the world to the global market is expected to increase accordingly. In particular, countries such as India, Korea and China are expected to witness rapid growth in the global facial aesthetics market by 2020.

Hyaluronic Acid Fillers the Fastest Growing Segment due to Greater Affordability and Good Safety Profiles

HA fillers are expected to be the fastest growing segment during the forecast period. The global market for HA fillers was valued at $1 billion in 2013 and is expected to exceed $2.5 billion by 2020 at a CAGR of 15%. HA filler procedures have become affordable, with many local entrants competing with the leading companies in this market. In Europe, HA fillers are sold at half the price of HA fillers sold in the US as there is intense competition in the market. Europe has many players, particularly in the dermal fillers segment, which has led to increasing competition driving down prices.

HA fillers are associated with good safety profiles and cause minimal patient discomfort which is the major driver for the rapid growth of this segment. The ingredients of HA fillers are a natural constituent of the human body as HA is responsible for the production of collagen. Unlike polymer fillers, HA fillers are completely biodegradable and do not contain any toxic monomers that lead to adverse effects. Procedures using HA fillers are non-surgical as HA enters the blood stream gradually and its effects are temporary.

Global Facial Aesthetics Market has High Exposure to Economic Volatility

The global facial aesthetics market is highly exposed to economic slowdown as procedures are elective and purely cosmetic. During times of economic slowdown, there is high risk of previous patients opting to defer facial aesthetic procedures which could negatively impact market growth. As these procedures are cosmetic, there is no harm if these procedures are not performed. The above figure shows how demand for facial aesthetic procedures decreased during the economic downturn in the US in 2008 and remained flat through to 2010. The growth in demand recovered only when the economy demonstrated sustained recovery in 2011. In 2012 and 2013 the US market witnessed a rapid increase in line with the rebounding US economy. This shows that facial aesthetic procedures are highly exposed to economic uncertainties which are a major threat to leading companies such as Allergan and Valeant in this market. As companies try to diversify into developing economies such as India and China, which show significantly greater potential for growth during the forecast period, the high dependence on the US economy will remain a major threat.

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

3. Analyst Commentary

4. Global Facial Aesthetics Market: Device Overview

  • 4.1. Facial Aesthetics
    • 4.1.1. Dermal Fillers
    • 4.1.2. Particle and Polymer Fillers
    • 4.1.3. Botox

5. Global Facial Aesthetics Market: Market Characterization

  • 5.1. Global Facial Aesthetics Market, Revenue, 2006-2020
  • 5.2. Botox Market, Global, Key Company Shares, 2013
  • 5.3. Dermal Fillers Market, Global, Key Company Shares, 2013
  • 5.4. Facial Aesthetics Market, Key Trends
    • 5.4.1. Topical Neurotoxins to Drive Future Growth of Botox Market
    • 5.4.2. Companies Focus on Autologous Injectables for Sustained Future Growth
    • 5.4.3. Survey Results Indicate Expanding Patient Demographics for Facial Injectables
  • 5.5. Market Dynamics
    • 5.5.1. Market Drivers
    • 5.5.2. Market Restraints

6. Global Facial Aesthetics Market: Segment Analysis and Forecasts

  • 6.1. Botox Market, Global, Revenue, 2006-2020
  • 6.2. Dermal Fillers Market, Global, Revenue, 2006-2020

7. Global Facial Aesthetics Market: Country Analysis and Forecasts

  • 7.1. Facial Aesthetics Market: Cross-country Analysis
  • 7.2. Historic and Forecast Revenue and Volume, by Country
    • 7.2.1. Facial Aesthetics Market, US, Revenue and Volume, 2006-2020
    • 7.2.2. Facial Aesthetics Market, Japan, Revenue and Volume, 2006-2020
    • 7.2.3. Facial Aesthetics Market, Germany, Revenue and Volume, 2006-2020
    • 7.2.4. Facial Aesthetics Market, France, Revenue, 2006-2013
    • 7.2.5. Facial Aesthetics Market, Korea, Revenue and Volume, 2006-2020
    • 7.2.6. Facial Aesthetics Market, Spain, Revenue, Volume, 2006-2020
    • 7.2.7. Facial Aesthetics Market, Italy, Revenue, Volume, 2006-2020
    • 7.2.8. Facial Aesthetics Market, Colombia, Revenue, Volume, 2006-2020
    • 7.2.9. Facial Aesthetics Market, China, Revenue, Volume, 2006-2020
    • 7.2.10. Facial Aesthetics Market, Turkey, Revenue, Volume, 2006-2020
    • 7.2.11. Facial Aesthetics Market, India, Revenue, 2006-2013
    • 7.2.12. Facial Aesthetics Market, Brazil, Revenue, 2006-2020

8. Global Facial Aesthetics Market: Competitive Landscape

  • 8.1. Comparison of Leading Botox Brands, 2014
  • 8.2. Comparison of Leading Hyaluronic Acid-Based Fillers, 2014
  • 8.3. Global Facial Aesthetics Market, Competitive Assessment
  • 8.4. Company Profiles
    • 8.4.1. Allergan
    • 8.4.2. Merz Aesthetics
    • 8.4.3. Galderma
    • 8.4.4. Valeant Pharmaceuticals International
    • 8.4.5. Mentor Worldwide
    • 8.4.6. Anika Therapeutics
    • 8.4.7. Anteis
    • 8.4.8. Adoderm
    • 8.4.9. Alcon Laboratories
    • 8.4.10. BioPolymer
    • 8.4.11. Contura International
    • 8.4.12. LCA Pharmaceutical
    • 8.4.13. Laboratories Orgev
    • 8.4.14. Polymekon
    • 8.4.15. Prollenium Medical Technologies
    • 8.4.16. Teoxane
    • 8.4.17. Zimmer
    • 8.4.18. Suneva Medical
    • 8.4.19. Revitacare
    • 8.4.20. Medytox
    • 8.4.21. HuGel

9. Global Facial Aesthetics Market: Product Pipeline Analysis

  • 9.1. Facial Aesthetics Market: List of Pipeline Products
    • 9.1.1. Dermal Fillers, List of Pipeline Products
    • 9.1.2. Botox, List of Pipeline Products
  • 9.2. Facial Aesthetics Market: Profiles of Key Pipeline Products
    • 9.2.1. Aquamid
    • 9.2.2. Autologous Globin Dermal Filler
    • 9.2.3. BioDermal Filler
    • 9.2.4. Collagen Scaffold - Aesthetic Procedures
    • 9.2.5. Dermal Filler
    • 9.2.6. Dermal Filler
    • 9.2.7. Gold Nanoparticle Dermal Filler
    • 9.2.8. Hyaluderm
    • 9.2.9. Injectable Dermal Filler
    • 9.2.10. Juvederm Volbella
    • 9.2.11. Juvederm Volift
    • 9.2.12. Juvederm Voluma XC
    • 9.2.13. Macdermol 18
    • 9.2.14. Macdermol 21
    • 9.2.15. Macdermol 24
    • 9.2.16. Macdermol 30
    • 9.2.17. Macdermol Bio Lift
    • 9.2.18. Macdermol Bio Revitalization
    • 9.2.19. Macdermol Body Contour
    • 9.2.20. Macdermol Hydro
    • 9.2.21. Macdermol Lips
    • 9.2.22. MacDermol R
    • 9.2.23. MacDermol S
    • 9.2.24. Macdermol Scalp Stimulation
    • 9.2.25. Macdermol Volume
    • 9.2.26. Matridex
    • 9.2.27. Matridur
    • 9.2.28. Matrigel
    • 9.2.29. Next Generation Elevess Dermal Filler
    • 9.2.30. Puragen
    • 9.2.31. Puragen Plus
    • 9.2.32. Restylane Touch
    • 9.2.33. Tenergel
    • 9.2.34. Wrinkle Filler
    • 9.2.35. RT-001
    • 9.2.36. RT-002
    • 9.2.37. ANT-1207
    • 9.2.38. NT-201

10. Facial Aesthetics Market: Consolidation Landscape

  • 10.1. Key Deals, 2014
    • 10.1.1. Valeant's Offer to Buy Allergan, 2014
    • 10.1.2. Deal Rationale
  • 10.2. Key Deals (2009-2013)
    • 10.2.1. Merz's Acquisition of Anteis, 2013
    • 10.2.2. Valeant's Acquisition of Medicis, 2012
    • 10.2.3. Merz Completes Acquisition of BioForm Medical, 2010
    • 10.2.4. Galderma's Acquisition of Q-Med, 2010
    • 10.2.5. Johnson & Johnson's Acquisition of Mentor, 2009

11. Appendix

  • 11.1. Definitions
    • 11.1.1. Facial Aesthetics
  • 11.2. Abbreviations
  • 11.3. Bibliography
  • 11.4. Research Methodology
    • 11.4.1. Secondary Research
    • 11.4.2. Primary Research
    • 11.4.3. Models
    • 11.4.4. Forecasts
    • 11.4.5. Expert Panel
  • 11.5. Contact Us
  • 11.6. Disclaimer

List of Tables

  • Table 1: Facial Aesthetics Market, Global, Revenue Forecast ($bn), 2006-2020
  • Table 2: Facial Aesthetics Market, Botox, Global, Key Company Share (%), 2013
  • Table 3: Facial Aesthetics Market, Dermal Fillers, Global, Key Company Share (%), 2013
  • Table 4: Facial Aesthetics Market, US Real GDP ($ trillion), Facial Aesthetic Procedures (million), 2014
  • Table 5: Facial Aesthetics Market, Botox, Global, Revenue Forecast ($bn), 2006-2020
  • Table 6: Facial Aesthetics Market, Dermal Fillers, Global, Revenue ($m), 2006-2020
  • Table 7: Facial Aesthetics Market, Global, Cross-country Analysis, CAGR (%), 2006-2020
  • Table 8: Facial Aesthetics Market, US, Revenue ($bn) and Number of Procedures (million), 2006-2020
  • Table 9: Facial Aesthetics Market, Japan, Revenue ($m) and Number of Procedures ('000), 2013-2020
  • Table 10: Facial Aesthetics Market, Germany, Revenue ($m) and Number of Procedures ('000), 2013-2020
  • Table 11: Facial Aesthetics Market, France, Revenue ($m) and Number of Procedures ('000), 2006-2020
  • Table 12: Facial Aesthetics Market, Korea, Revenue ($m) and Number of Procedures ('000), 2006-2020
  • Table 13: Facial Aesthetics Market, Spain, Revenue ($m) and Number of Procedures ('000), 2006-2020
  • Table 14: Facial Aesthetics Market, Italy, Revenue ($m) and Number of Procedures ('000), 2013-2020
  • Table 15: Facial Aesthetics Market, Colombia, Revenue ($m) and Number of Procedures ('000), 2006-2020
  • Table 16: Facial Aesthetics Market, China, Revenue ($m) and Number of Procedures ('000), 2013-2020
  • Table 17: Facial Aesthetics Market, Turkey, Revenue ($m) and Number of Procedures ('000), 2013-2020
  • Table 18: Facial Aesthetics Market, India, Revenue ($m) and Number of Procedures ('000), 2006-2020
  • Table 19: Facial Aesthetics Market, Brazil, Revenue ($m) and Number of Procedures ('000), 2006-2020
  • Table 20: Facial Aesthetics Market, Allergan, Key Marketed Products, 2014
  • Table 21: Facial Aesthetics Market, Merz Aesthetics, Key Marketed Products, 2014
  • Table 22: Facial Aesthetics Market, Galderma, Key Marketed Products, 2014
  • Table 23: Facial Aesthetics Market, Valeant Pharmaceuticals International, Key Marketed Products, 2013
  • Table 24: Facial Aesthetics Market, Mentor Worldwide LLC, Key Marketed Products, 2013
  • Table 25: Facial Aesthetics Market, Anika Therapeutics, Key Marketed Products, 2013
  • Table 26: Facial Aesthetics Market, Anteis, Key Marketed Products, 2013
  • Table 27: Facial Aesthetics Market, Adoderm, Key Marketed Products, 2013
  • Table 28: Facial Aesthetics Market, Alcon Laboratories, Key Marketed Products, 2013
  • Table 29: Facial Aesthetics Market, BioPolymer, Key Marketed Products, 2013
  • Table 30: Facial Aesthetics Market, Contura International, Key Marketed Products, 2013
  • Table 31: Facial Aesthetics Market, LCA Pharmaceutical, Key Marketed Products, 2013
  • Table 32: Facial Aesthetics Market, Laboratories Orgev, Key Marketed Products, 2014
  • Table 33: Facial Aesthetics Market, Polymekon, Key Marketed Products, 2014
  • Table 34: Facial Aesthetics Market, Prollenium Medical Technologies, Key Marketed Products, 2014
  • Table 35: Facial Aesthetics Market, Teoxane, Key Marketed Products, 2014
  • Table 36: Facial Aesthetics Market, Zimmer, Key Marketed Products, 2014
  • Table 37: Facial Aesthetics Market, Suneva Medical, Key Marketed Products, 2014
  • Table 38: Facial Aesthetics Market, Revitacare, Key Marketed Products, 2014
  • Table 39: Facial Aesthetics Market, Medytox, Key Marketed Products, 2014
  • Table 40: Facial Aesthetics Market, HuGel, Key Marketed Products, 2014
  • Table 41: Facial Aesthetics Market, Dermal Fillers, Global, List of Pipeline Products, 2014
  • Table 42: Facial Aesthetics Market, Botox, Global, List of Pipeline Products, 2014
  • Table 43: Facial Aesthetics Market, Aquamid, Product Status, 2014
  • Table 44: Facial Aesthetics Market, Autologous Globin Dermal Filler, Product Status, 2014
  • Table 45: Facial Aesthetics Market, BioDermal Filler, Product Status, 2014
  • Table 46: Facial Aesthetics Market, Collagen Scaffold Aesthetic Procedures, Product Status, 2013
  • Table 47: Facial Aesthetics Market, Dermal Filler, Product Status, 2013
  • Table 48: Facial Aesthetics Market, Dermal Filler, Product Status, 2013
  • Table 49: Facial Aesthetics Market, Gold Nanoparticle Dermal Filler, Product Status, 2013
  • Table 50: Facial Aesthetics Market, Hyaluderm, Product Status, 2013
  • Table 51: Facial Aesthetics Market, Injectable Dermal Filler, Product Status, 2013
  • Table 52: Facial Aesthetics Market, Juvederm Volbella, Product Status, 2014
  • Table 53: Facial Aesthetics Market, Juvederm Volift, Product Status, 2014
  • Table 54: Facial Aesthetics Market, Juvederm Voluma XC, Product Status, 2014
  • Table 55: Facial Aesthetics Market, Macdermol 18, Product Status, 2013
  • Table 56: Facial Aesthetics Market, Macdermol 21, Product Status, 2014
  • Table 57: Facial Aesthetics Market, Macdermol 24, Product Status, 2013
  • Table 58: Facial Aesthetics Market, Macdermol 30, Product Status, 2013
  • Table 59: Facial Aesthetics Market, Macdermol Bio Lift, Product Status, 2014
  • Table 60: Facial Aesthetics Market, Macdermol Bio Revitalization, Product Status, 2014
  • Table 61: Facial Aesthetics Market, Macdermol Body Contour, Product Status, 2014
  • Table 62: Facial Aesthetics Market, Macdermol Hydro, Product Status, 2014
  • Table 63: Facial Aesthetics Market, Macdermol Lips, Product Status, 2013
  • Table 64: Facial Aesthetics Market, MacDermol R, Product Status, 2014
  • Table 65: Facial Aesthetics Market, MacDermol S, Product Status, 2014
  • Table 66: Facial Aesthetics Market, Macdermol Scalp Stimulation, Product Status, 2013
  • Table 67: Facial Aesthetics Market, Macdermol Volume, Product Status, 2014
  • Table 68: Facial Aesthetics Market, Matridex, Product Status, 2014
  • Table 69: Facial Aesthetics Market, Matridur, Product Status, 2014
  • Table 70: Facial Aesthetics Market, Matrigel, Product Status, 2014
  • Table 71: Facial Aesthetics Market, Next Generation Elevess Dermal Filler, Product Status, 2014
  • Table 72: Facial Aesthetics Market, Puragen, Product Status, 2014
  • Table 73: Facial Aesthetics Market, Puragen Plus, Product Status, 2014
  • Table 74: Facial Aesthetics Market, Restylane Touch, Product Status, 2014
  • Table 75: Facial Aesthetics Market, Tenergel, Product Status, 2014
  • Table 76: Facial Aesthetics Market, Wrinkle Filler, Product Status, 2014
  • Table 77: Facial Aesthetics Market, RT-001, Product Status, 2014
  • Table 78: Facial Aesthetics Market, RT-002, Product Status, 2014
  • Table 79: Facial Aesthetics Market, ANT-1207, Product Status, 2014
  • Table 80: Facial Aesthetics Market, NT-201, Product Status, 2014

List of Figures

  • Figure 1: Facial Aesthetics Market, Device Overview
  • Figure 2: Facial Aesthetics Market, Global, Revenue ($bn), 2006-2020
  • Figure 3: Facial Aesthetics Market, Botox, Global, Key Company Share (%), 2013
  • Figure 4: Facial Aesthetics Market, Botox, US, Botox Cosmetic Price Trend, 1997-2009
  • Figure 5: Facial Aesthetics Market, Dermal Fillers, Global, Key Company Share (%), 2013
  • Figure 6: Facial Aesthetics Market, Market Trends
  • Figure 7: Facial Aesthetics Market, Market Dynamics
  • Figure 8: Facial Aesthetics Market, National Average Physician Fee, US, 2013
  • Figure 9: Facial Aesthetics Market, Studies Indicating Advantages of Dermal Fillers with Lidocaine, 2014
  • Figure 10: Facial Aesthetics Market, Botox, Global, Revenue Forecast ($bn), 2006-2020
  • Figure 11: Facial Aesthetics Market, Dermal Fillers, Global, Revenue Forecast ($bn), 2006-2020
  • Figure 12: Facial Aesthetics Market, Global, Cross-country Analysis, CAGR (%), 2006-2020
  • Figure 13: Facial Aesthetics Market, US, Cross-segment Analysis, CAGR (%), 2006-2020
  • Figure 14: Facial Aesthetics Market, US, Revenue ($bn) and Number of Procedures (million), 2006-2020
  • Figure 15: Facial Aesthetics Market, Japan, Cross-segment Analysis, CAGR (%), 2006-2020
  • Figure 16: Facial Aesthetics Market, Japan, Revenue and Number of Procedures ('000), 2006-2020
  • Figure 17: Facial Aesthetics Market, Germany, Cross-segment Analysis, CAGR (%), 2006-2020
  • Figure 18: Facial Aesthetics Market, Germany, Revenue ($m) and Number of Procedures ('000), 2006-2020
  • Figure 19: Facial Aesthetics Market, France, Cross-segment Analysis, CAGR (%), 2006-2020
  • Figure 20: Facial Aesthetics Market, France, Revenue ($m) and Number of Procedures ('000), 2006-2020
  • Figure 21: Facial Aesthetics Market, Korea, Cross-segment Analysis, CAGR (%), 2006-2020
  • Figure 22: Facial Aesthetics Market, Korea, Revenue ($m) and Number of Procedures ('000), 2006-2020
  • Figure 23: Facial Aesthetics Market, Spain, Cross-segment Analysis, CAGR (%), 2006-2020
  • Figure 24: Facial Aesthetics Market, Spain, Revenue ($m) and Number of Procedures ('000), 2006-2020
  • Figure 25: Facial Aesthetics Market, Italy, Cross-segment Analysis, CAGR (%), 2006-2020
  • Figure 26: Facial Aesthetics Market, Italy, Revenue ($m) and Number of Procedures ('000), 2006-2020
  • Figure 27: Facial Aesthetics Market, Colombia, Cross-segment Analysis, CAGR (%), 2006-2020
  • Figure 28: Facial Aesthetics Market, Colombia, Revenue ($m) and Number of Procedures ('000), 2006-2020
  • Figure 29: Facial Aesthetics Market, China, Cross-segment Analysis, CAGR (%), 2006-2020
  • Figure 30: Facial Aesthetics Market, China, Revenue ($m) and Number of Procedures ('000), 2006-2020
  • Figure 31: Facial Aesthetics Market, Turkey, Cross-segment Analysis, CAGR (%), 2006-2020
  • Figure 32: Facial Aesthetics Market, Turkey, Revenue ($m) and Number of Procedures ('000), 2006-2020
  • Figure 33: Facial Aesthetics Market, India, Cross-segment Analysis, CAGR (%), 2006-2020
  • Figure 34: Facial Aesthetics Market, India, Revenue ($m) and Number of Procedures ('000), 2006-2020
  • Figure 35: Facial Aesthetics Market, Brazil, Cross-segment Analysis, CAGR (%), 2006-2020
  • Figure 36: Facial Aesthetics Market, Brazil, Revenue ($m) and Number of Procedures ('000), 2006-2020
  • Figure 37: Facial Aesthetics Market, Comparison of Leading Botox Brands, 2014
  • Figure 38: Facial Aesthetics Market, Comparison of Leading Dermal Fillers, 2014
  • Figure 39: Facial Aesthetics Market, Global, Competitive Assessment, 2014
  • Figure 40: Facial Aesthetics Market, Pipeline Products Summary, 2014
Back to Top